ScripBliss Biopharmaceutical (Hangzhou) (BlissBio), a Chinese developer of antibody-drug conjugates (ADCs), will rely on itself to advance BB-1701, a HER2-targeting ADC carrying the microtubule inhibitor e
ScripBy following AstraZeneca in acquiring its own in vivo CAR-T company, AbbVie can now hedge its bets with investments across two distinct delivery platforms for the novel products. AbbVie’s decision t
In VivoAmid mounting global concerns over uncontrolled hypertension and its ties to cardiorenal and metabolic disorders, Pennsylvania-based biotech Mineralys Therapeutics is making waves with its novel aldos
Pink SheetA US Centers for Disease Control and Prevention panel’s divided endorsement of Merck & Co .’s Enflonsia (clesrovimab-cfor) for prevention of respiratory syncytial virus in infants suggests that p